or
forgot password
  • cancer clinical trials in oregon

  • Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Children's Hospital
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Oregon City, Oregon 97045
    Carcinoma, Renal Cell
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Providence Cancer Center at Providence Portland Medical Center
    Portland, Oregon 97213-2967
    Colorectal Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Providence Cancer Center -The Plaza
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
    CCOP - Columbia River Oncology Program
    Portland, Oregon 97225
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Diarrhea
    Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
    Willamette Valley Cancer Center

    Trial Locations
    Willamette Valley Cancer Center
    Northwest Cancer Specialists, P.C.
    Advanced Breast Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Earle A Chiles Research Institute, Providence Cancer Center
    Portland, Oregon 97213
    Melanoma
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Malignant Mesothelioma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Oregon Health and Science University
    Portland, Oregon 97201
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Oregon Health Science University
    Carcinoid Syndrome
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Legacy Mount Hood Medical Center

    Trial Locations
    Legacy Mount Hood Medical Center
    Providence Milwaukie Hospital
    CCOP - Columbia River Oncology Program
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Northwest Cancer Specialists at Rose Quarter Cancer Center
    Salem Hospital Regional Cancer Care Services
    Legacy Meridian Park Hospital
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Advanced Breast Cancer, Breast Cancer
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    Oregon Health and Sciences University

    Trial Locations
    Oregon Health and Sciences University
    Providence Medical Center
    Oregon Urology Institute
    Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Three Rivers Community Hospital

    Trial Locations
    Three Rivers Community Hospital
    Legacy Mount Hood Medical Center
    Providence Medford Medical Center
    Asante Health System
    Rogue Valley Medical Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Providence Willamette Falls Medical Center
    Adventist Medical Center
    Providence Portland Medical Center
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer